Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 499
Selected: 0
NCT IDTitle
NCT07110090Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)
NCT06146946Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
NCT06858969Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer
NCT01829841A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer
NCT06750861QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC
NCT02981641IORT Versus CCRT for Pancreatic Cancer
NCT04819685Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury
NCT06405256Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain Metastases
NCT03844360Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
NCT05235100Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma (SPARE-02)
NCT0608476768Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer
NCT05983094Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer
NCT06691594Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy
NCT07037680Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT
NCT03708042A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer
NCT06419673Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer
NCT07013461International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
NCT06202001Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients
NCT05327517Surgery or Chemoradiotherapy for Cervical Esophageal Cancer
NCT06857747Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.
NCT06501976An Exploratory Study of Lurbinectedin With Radiotherapy in Locally-advanced SCLC After First-line Therapy
NCT06820320Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy
NCT06539559Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer
NCT04821765Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
NCT04074538the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
NCT07366658Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients
NCT05904015The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC
NCT02395705Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma
NCT07040098Optimizing Immunotherapy Combined With Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
NCT04498793Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer
NCT07359404Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC
NCT07204041Efficacy and Safety of XTD Regimen (Selinexor, Thalidomide and Dexamethasone) in Adult Patients With Relapsed/Refractory LCH
NCT02734680IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer
NCT06314542Quantitative Evaluation of the Impact of Relaxing Eligibility Criteria for Lung Cancer Based on Real-world Data
NCT06354036Transhiatal Tunnel Valvuloplasty for Reconstruction Following the Laparoscopic Proximal Gastrectomy
NCT02691871Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR
NCT05865132Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction
NCT02971345Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
NCT06492629Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma
NCT05385926Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma
NCT00714077Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer
NCT07164872Neoadjuvant Chemotherapy Combined With Preoperative Radiotherapy for Locally Advanced Breast Cancer
NCT07156019Sintilimab in Combination With Surufatinib and Temozolomide in the Advanced Neuroendocrine Carcinoma
NCT05974007Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC
NCT06768125Hypofractionated Radiotherapy for HNSCC in Elderly Patients
NCT05747313Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer
NCT06591078Evaluation of Clinical Efficacy of Acupuncture in Improving Immune Response in Patients With Cervical Cancer
NCT06435767Quantitative Nodal Burden as a Determinant Identifying Ampullary Adenocarcinoma Patients Benefiting From Adjuvant Chemotherapy
NCT06848842Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases
NCT06577961Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients